申请人:PROTAGONIST THERAPEUTICS ,INC.
公开号:US20170313754A1
公开(公告)日:2017-11-02
The present invention provides novel hepcidin analogues, and related methods of using these hepcidin analogues to treat or prevent a variety of diseases and disorders, including iron overload diseases such as hereditary hemochromatosis, iron-loading anemias, and other conditions and disorders described herein.